Skip to content

Effects of a Strength Training Programme in Institutionalized Older Adults With Sarcopenia.

Effects of a High-intensity Interval Strength Training Programme in Institutionalized Older Adults With Sarcopenia: a Randomized Clinical Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07315789
Enrollment
164
Registered
2026-01-02
Start date
2022-02-01
Completion date
2025-12-15
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIIT, Institutionalized Older Adults, Sarcopenia in Elderly

Brief summary

Sarcopenia is one of the main problems in the elderly population. The concept of disease has evolved, as have its treatment strategies. Among these is high-intensity interval training (HIIT). This approach has been little studied in older adults with sarcopenia, especially in institutionalized older adults in nursing homes. So this will be the objective of the study. A randomised clinical trial is being conducted to analyse how these diagnostic criteria for sarcopenia evolve after the application of HIIT compared to a control group.

Interventions

OTHERHigh-intensity interval strength training: therapeutic exercise programme.

A 12-week high-intensity interval strenght training (HIITs) programme is developed with basic exercises adapted to the living environment of older people. Progress in the exercises over the twelve weeks is measured using the maximum weight that can be lifted in one repetition (1-RM), maximum heart rate (MHR) and the Borg scale.

Sponsors

University of Extremadura
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* older adults who have been institutionalized for at least one year * older adults who are institutionalized with clinical suspicion of sarcopenia according to the Sarc-F questionnaire and muscle strength criteria * older adults residing in the community of Extremadura.

Exclusion criteria

* present cognitive impairment (score \<24 Mini-Mental State Examination) * primary, serious, or chronic diseases that could explain the decrease in muscle strength and the other diagnostic variables of the participants * diseases or physical disorders that hinder the assessment of the participants; -use of drugs that may affect muscle strength and mass.

Design outcomes

Primary

MeasureTime frameDescription
Hand grip strenghtThrice at the baseline: at the start, at 8 weeks and at 12 weeks.The researchers used the JAMAR dynamometer

Secondary

MeasureTime frameDescription
Muscular mass / appendicular skeletal mass (ASM)Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.The researchers used bioimpedance analysis with Tanita MC780-S MA Multifrequency.
Physical performanceThrice at the baseline: at the start, at 8 weeks and at 12 weeks.The researchers used the scale: "Short Physical Performance Battery" (SPPB).
Physical performance 2Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.The researchers used the test: "Timed Up and Go" (TUG).

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026